Rapid Micro Biosystems Secures Follow-on Multi-System Order from Samsung Biologics for Growth Direct Platform

Rapid Micro Biosystems has announced a new multi-system order from Samsung Biologics for its Growth Direct platform. This follow-on order builds on the companies' existing partnership and supports Samsung's expansion of the Growth Direct platform to automate microbial quality control across its manufacturing network. The Growth Direct system automates and modernizes microbial quality control testing workflows, delivering faster results, greater accuracy, and increased operational efficiency. The partnership aims to advance automated, integrated microbiology quality control in healthcare product manufacturing.